TAIWAN BIOMATERIAL CO., LTD. Taiwan Biomaterial Co., Ltd. Share Price
Equities
6649
TW0006649007
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.1 TWD | -1.36% |
|
-1.69% | -7.03% |
| Sales 2022 | 127M 3.93M 328M | Sales 2023 | 72.84M 2.25M 188M | Capitalization | 1.31B 40.63M 3.39B |
|---|---|---|---|---|---|
| Net income 2022 | 33M 1.02M 84.98M | Net income 2023 | -10M -309K -25.75M | EV / Sales 2022 | 9.37 x |
| Net cash position 2022 | 264M 8.16M 680M | Net cash position 2023 | 243M 7.53M 627M | EV / Sales 2023 | 14.7 x |
| P/E ratio 2022 |
42
x | P/E ratio 2023 |
-130
x | Employees | - |
| Yield 2022 |
0.58% | Yield 2023 |
-
| Free-Float | 56.6% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.36% | ||
| 1 week | -1.69% | ||
| Current month | -0.68% | ||
| 1 month | -2.84% | ||
| 3 months | +2.65% | ||
| 6 months | -9.06% | ||
| Current year | -7.03% |
1 week
28.85
29.75
1 month
28.8030.80
Current year
24.9534.00
1 year
24.9544.80
3 years
21.9049.00
5 years
18.2056.00
10 years
18.2081.00
| Managers | Title | Age | Since |
|---|---|---|---|
Wen Hsi Wang
CEO | Chief Executive Officer | - | 12/12/12 |
Chun Jen Liao
FOU | Founder | - | 12/12/12 |
Peter Chen
DFI | Director of Finance/CFO | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chun Te Lue
BRD | Director/Board Member | - | 30/17/30 |
Chih Mao Lin
CHM | Chairman | - | 10/20/10 |
Ming Jen Chan
BRD | Director/Board Member | - | 27/17/27 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/24/29 | 29.1 | -1.36% | 38 869 |
| 28/24/28 | 29.5 | +0.17% | 4,021 |
| 27/24/27 | 29.45 | +1.03% | 13,087 |
| 24/24/24 | 29.15 | -2.02% | 51,644 |
| 23/24/23 | 29.75 | +0.51% | 17,106 |
End-of-day quote Taipei Exchange, May 29, 2024
More quotes
Taiwan Biomaterial Co., Ltd. is a Taiwan-based company mainly engaged in provision of medical equipment. The products are still in research and development stage. The Company's subsidiary TAIWAN MEDICAL RAPID PROTOTYPING CO., LTD.(TRP) is engaged in trial production of medical equipment. Main products include foam artificial meninges products, stroke thrombus aspiration catheter products, repair and regeneration products for early degenerative arthritis and others.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.03% | 38.48M | |
| +75.71% | 12.56B | |
| -23.77% | 7.47B | |
| +7.58% | 6.75B | |
| +11.63% | 5.5B | |
| -16.58% | 4.94B | |
| +29.47% | 4.66B | |
| -25.47% | 3.75B | |
| -23.48% | 2.92B | |
| -2.23% | 1.98B |
- Stock Market
- Equities
- 6649 Stock
